scholarly journals RhoBTB1 interacts with ROCKs and inhibits invasion

2019 ◽  
Vol 476 (17) ◽  
pp. 2499-2514 ◽  
Author(s):  
Raquel B. Haga ◽  
Ritu Garg ◽  
Francesca Collu ◽  
Bárbara Borda D'Agua ◽  
Sofia T. Menéndez ◽  
...  

Abstract RhoBTB1 is an atypical Rho GTPase with two BTB domains in addition to its Rho domain. Although most Rho GTPases regulate actin cytoskeletal dynamics, RhoBTB1 is not known to affect cell shape or motility. We report that RhoBTB1 depletion increases prostate cancer cell invasion and induces elongation in Matrigel, a phenotype similar to that induced by depletion of ROCK1 and ROCK2. We demonstrate that RhoBTB1 associates with ROCK1 and ROCK2 and its association with ROCK1 is via its Rho domain. The Rho domain binds to the coiled-coil region of ROCK1 close to its kinase domain. We identify two amino acids within the Rho domain that alter RhoBTB1 association with ROCK1. RhoBTB1 is a substrate for ROCK1, and mutation of putative phosphorylation sites reduces its association with Cullin3, a scaffold for ubiquitin ligases. We propose that RhoBTB1 suppresses cancer cell invasion through interacting with ROCKs, which in turn regulate its association with Cullin3. Via Cullin3, RhoBTB1 has the potential to affect protein degradation.

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Gardiyawasam Kalpana ◽  
Christopher Figy ◽  
Jingwei Feng ◽  
Claire Tipton ◽  
Julius N. De Castro ◽  
...  

AbstractRaf-1 kinase inhibitor protein was initially discovered as a physiological kinase inhibitor of the MAPK signaling pathway and was later shown to suppress cancer cell invasion and metastasis. Yet, the molecular mechanism through which RKIP executes its effects is not completely defined. RhoA has both a pro- and anti-metastatic cell-context dependent functions. Given that Rho GTPases primarily function on actin cytoskeleton dynamics and cell movement regulation, it is possible that one way RKIP hinders cancer cell invasion/metastasis is by targeting these proteins. Here we show that RKIP inhibits cancer cell invasion and metastasis by stimulating RhoA anti-tumorigenic functions. Mechanistically, RKIP activates RhoA in an Erk2 and GEF-H1 dependent manner to enhance E-cadherin membrane localization and inhibit CCL5 expression.


2017 ◽  
Vol 19 (suppl_1) ◽  
pp. i5-i5 ◽  
Author(s):  
Mr Teklu Egnuni ◽  
Prof Valerie Speirs ◽  
Dr Aruna Chakrabarty ◽  
Dr Heiko Wurdak ◽  
Dr Mihaela Lorger ◽  
...  

2009 ◽  
Vol 2009 ◽  
pp. 1-6 ◽  
Author(s):  
Huixing Feng ◽  
Jianhua Zhang ◽  
Xi Li ◽  
Wei Ning Chen

Hepatitus B virus (HBV) is a major cause of the development of hepatpcellular carcinoma (HCC). One of the significant characteristics of tumor progression is cell migration which is reflective of cytoskeletal dynamics. The Rho GTPases contribute to a multiple cellular processes, including the cellular cytoskeletal reorganization and motility. It has been found that some Rho GTPases have oncogenic activity and can promote cancer cell invasion. Here we discuss one of the Rho GTPases, Rac1 can be activated by HBV replication and such activation results in the high motility of HBV-replicating cells. The enhanced cell motility can be interestingly alleviated by the mutation at the sites of proline rich domain located in HBX. Our findings may provide new insights on the mechanism of HCC development associated with chronic HBV infection.


2006 ◽  
Vol 97 (9) ◽  
pp. 848-853 ◽  
Author(s):  
Toshiyuki Kusama ◽  
Mutsuko Mukai ◽  
Hiroko Endo ◽  
Osamu Ishikawa ◽  
Masaharu Tatsuta ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document